The p53 activator overcomes resistance to ALK inhibitors sorted by
relevance

Admin09.09.2021

The p53 activator overcomes resistance to ALK inhibitors

8501
Admin16.09.2021

The p53 activator overcomes resistance to ALK inhibitors

1303
Admin02.08.2021

(PDF) The p53 activator overcomes resistance to ALK

1403
Admin15.09.2021

Bcl-2 Inhibition Reciprocally Overcomes Resistance to p53

1409
Admin19.09.2021

The p53 activator overcomes resistance to ALK inhibitors

7004
Admin17.09.2021

The p53 activator overcomes resistance to ALK inhibitors

4306
Admin25.07.2021

Bcl-2 Inhibition Reciprocally Overcomes Resistance to p53

9303
Admin24.08.2021

Combination of ALK inhibitor and p53 activator effectively

906
Admin21.08.2021

p53 Activation by RG Abrogates Inherent Resistance to Bcl

5402
Admin08.09.2021

Activation of the p53 response upon co-treatment with

6402
Admin18.09.2021

Bcl-2 Inhibition Reciprocally Overcomes Resistance to p53

6907
Admin11.09.2021

美国APExBIO中文官网 - RG7112|MDM2 inhibitor, first clinical|CAS

7907
Admin09.08.2021

美国APExBIO中文官网 - RG7112|MDM2 inhibitor, first clinical|CAS

3505
Admin29.07.2021

| TRIB2-mediated resistance to chemotherapeutics is via

4007
Admin01.09.2021

p53 Activator RG Overcomes the Resistance of AML Cells

Admin27.09.2021

(PDF) Lenvatinib in combination with golvatinib overcomes

206
Admin09.09.2021

Multiple receptor tyrosine kinase activation related to

7700
Admin15.08.2021

Activation of the p53 pathway by the MDM2 inhibitor nutlin

3401
Admin02.08.2021

ALK inhibitors elicit cell-cycle arrest, but not cell

6802
Admin30.07.2021

(PDF) PAK signalling drives acquired drug resistance to

9908
Admin17.07.2021

(PDF) Mutant p53 improves cancer cells resistance to

1007